Stocks · Health care · Pharmaceutical Preparations

Janux Therapeutics, Inc.

JANX Clue Score43

United States Fiscal year ends December CIK 0001817713 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (120 mo)

$207.28M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$365.17M

$6.73M on a plan · $19.32M straight out of an exercise

Sold at will

$339.13M

60 of 103 sales

Net

−$157.90M

−$131.85M against sales at will